The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
The global CRM197 market was valued at US$ 172.2 million in 2023 and is anticipated to reach US$ 240.8 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
This report aims to provide a comprehensive presentation of the global market for CRM197, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRM197.
Report Scope
The CRM197 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRM197 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRM197 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
Segment by Type
Research Grade CRM197
cGMP Grade CRM197
Segment by Application
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRM197 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.
The global CRM197 market was valued at US$ 172.2 million in 2023 and is anticipated to reach US$ 240.8 million by 2030, witnessing a CAGR of 5.3% during the forecast period 2024-2030.
Pfizer Inc is one of the most important global manufacturers of CRM197, holds a share of over 85%. North America is the largest market, occupied for over 75%. In terms of type, research grade is the largest segment, with a share of over 85%. And in terms of application, pneumococcal conjugate vaccine segment holds a share of about 90%.
This report aims to provide a comprehensive presentation of the global market for CRM197, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CRM197.
Report Scope
The CRM197 market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global CRM197 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CRM197 companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer Inc.
Ligand Pharmaceuticals
CanSino Biologic
Beijing Kexing Biology Product
Scarab Genomics
Xpress Biologics
Fina Biosolutions
Eubiologics
EirGenix Inc.
Segment by Type
Research Grade CRM197
cGMP Grade CRM197
Segment by Application
Pneumococcal Conjugate Vaccine
Meningococcal Polysaccharide Conjugate Vaccine
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CRM197 companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CRM197 Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research Grade CRM197
1.2.3 cGMP Grade CRM197
1.3 Market by Application
1.3.1 Global CRM197 Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pneumococcal Conjugate Vaccine
1.3.3 Meningococcal Polysaccharide Conjugate Vaccine
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CRM197 Market Perspective (2019-2030)
2.2 CRM197 Growth Trends by Region
2.2.1 Global CRM197 Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 CRM197 Historic Market Size by Region (2019-2024)
2.2.3 CRM197 Forecasted Market Size by Region (2025-2030)
2.3 CRM197 Market Dynamics
2.3.1 CRM197 Industry Trends
2.3.2 CRM197 Market Drivers
2.3.3 CRM197 Market Challenges
2.3.4 CRM197 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CRM197 Players by Revenue
3.1.1 Global Top CRM197 Players by Revenue (2019-2024)
3.1.2 Global CRM197 Revenue Market Share by Players (2019-2024)
3.2 Global CRM197 Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CRM197 Revenue
3.4 Global CRM197 Market Concentration Ratio
3.4.1 Global CRM197 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CRM197 Revenue in 2023
3.5 CRM197 Key Players Head office and Area Served
3.6 Key Players CRM197 Product Solution and Service
3.7 Date of Enter into CRM197 Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CRM197 Breakdown Data by Type
4.1 Global CRM197 Historic Market Size by Type (2019-2024)
4.2 Global CRM197 Forecasted Market Size by Type (2025-2030)
5 CRM197 Breakdown Data by Application
5.1 Global CRM197 Historic Market Size by Application (2019-2024)
5.2 Global CRM197 Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America CRM197 Market Size (2019-2030)
6.2 North America CRM197 Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America CRM197 Market Size by Country (2019-2024)
6.4 North America CRM197 Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CRM197 Market Size (2019-2030)
7.2 Europe CRM197 Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe CRM197 Market Size by Country (2019-2024)
7.4 Europe CRM197 Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CRM197 Market Size (2019-2030)
8.2 Asia-Pacific CRM197 Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific CRM197 Market Size by Region (2019-2024)
8.4 Asia-Pacific CRM197 Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CRM197 Market Size (2019-2030)
9.2 Latin America CRM197 Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America CRM197 Market Size by Country (2019-2024)
9.4 Latin America CRM197 Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CRM197 Market Size (2019-2030)
10.2 Middle East & Africa CRM197 Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa CRM197 Market Size by Country (2019-2024)
10.4 Middle East & Africa CRM197 Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Detail
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. CRM197 Introduction
11.1.4 Pfizer Inc. Revenue in CRM197 Business (2019-2024)
11.1.5 Pfizer Inc. Recent Development
11.2 Ligand Pharmaceuticals
11.2.1 Ligand Pharmaceuticals Company Detail
11.2.2 Ligand Pharmaceuticals Business Overview
11.2.3 Ligand Pharmaceuticals CRM197 Introduction
11.2.4 Ligand Pharmaceuticals Revenue in CRM197 Business (2019-2024)
11.2.5 Ligand Pharmaceuticals Recent Development
11.3 CanSino Biologic
11.3.1 CanSino Biologic Company Detail
11.3.2 CanSino Biologic Business Overview
11.3.3 CanSino Biologic CRM197 Introduction
11.3.4 CanSino Biologic Revenue in CRM197 Business (2019-2024)
11.3.5 CanSino Biologic Recent Development
11.4 Beijing Kexing Biology Product
11.4.1 Beijing Kexing Biology Product Company Detail
11.4.2 Beijing Kexing Biology Product Business Overview
11.4.3 Beijing Kexing Biology Product CRM197 Introduction
11.4.4 Beijing Kexing Biology Product Revenue in CRM197 Business (2019-2024)
11.4.5 Beijing Kexing Biology Product Recent Development
11.5 Scarab Genomics
11.5.1 Scarab Genomics Company Detail
11.5.2 Scarab Genomics Business Overview
11.5.3 Scarab Genomics CRM197 Introduction
11.5.4 Scarab Genomics Revenue in CRM197 Business (2019-2024)
11.5.5 Scarab Genomics Recent Development
11.6 Xpress Biologics
11.6.1 Xpress Biologics Company Detail
11.6.2 Xpress Biologics Business Overview
11.6.3 Xpress Biologics CRM197 Introduction
11.6.4 Xpress Biologics Revenue in CRM197 Business (2019-2024)
11.6.5 Xpress Biologics Recent Development
11.7 Fina Biosolutions
11.7.1 Fina Biosolutions Company Detail
11.7.2 Fina Biosolutions Business Overview
11.7.3 Fina Biosolutions CRM197 Introduction
11.7.4 Fina Biosolutions Revenue in CRM197 Business (2019-2024)
11.7.5 Fina Biosolutions Recent Development
11.8 Eubiologics
11.8.1 Eubiologics Company Detail
11.8.2 Eubiologics Business Overview
11.8.3 Eubiologics CRM197 Introduction
11.8.4 Eubiologics Revenue in CRM197 Business (2019-2024)
11.8.5 Eubiologics Recent Development
11.9 EirGenix Inc.
11.9.1 EirGenix Inc. Company Detail
11.9.2 EirGenix Inc. Business Overview
11.9.3 EirGenix Inc. CRM197 Introduction
11.9.4 EirGenix Inc. Revenue in CRM197 Business (2019-2024)
11.9.5 EirGenix Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
